Blue Venture Funds
Venture capitalSeed–Late Stage · 21 people tracked
Investment thesis
Blue Venture Fund believes that meaningful innovation in healthcare requires deep partnership with Blue Plans and industry participants throughout the investment lifecycle. The firm sources opportunities in markets where Blue Plans seek to partner, engages formal advisory groups across healthcare disciplines to refine products, and provides hands-on support in commercialization and health plan contracting. The fund emphasizes long-term strategic relationships, helping entrepreneurs navigate the healthcare system and grow within it, grounded in over a decade of experience enabling healthcare innovation adoption.
Source: firm website, verified Jul 21, 2026.
Team · 21 people
from the firm's websiteWhat they invest in
from 1 of 63 portfolio companiesMarketing Tech ×1SaaS ×1
Investments · showing 60 of 63
founders shown can be your intro pathCision PRWeb is a press release distribution and publicity platform that helps organizations communicate with target audiences through search, social media, and industry-specific partner networks including bloggers and influencers.
Marketing TechSaaS
Frequently asked questions
- What stage does Blue Venture Funds invest at?
- Blue Venture Funds invests at the Seed, Series A, Series B, Series C, Growth, Late Stage stages.
- What sectors does Blue Venture Funds focus on?
- Blue Venture Funds focuses on Digital Health, Healthtech, Medical Devices.
Similar investors
B Capital is a venture capital firm managing over $12 billion in assets with a stage-based fund approach. The firm invests across early to late-stage companies in technology, healthcare, and energy & resilience sectors, with 200+ portfolio companies and 9 global offices.
DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.
GV is Alphabet's venture capital arm, established in 2009 as Google Ventures. Operating with long time horizons and over $13 billion in assets under management, the firm invests across technology and life sciences sectors from seed to growth stages, supporting 400 active portfolio companies across North America, Europe, and Israel.
USVP is a venture capital firm with over 40 years of history across four generations of technology investing. The firm has deployed $4.7B across 542 companies, generating 97 IPOs, and combines 150 years of combined operating experience with deep expertise in enterprise software, security, consumer technology, and healthcare.
A venture capital firm that supports founders developing transformative solutions across interconnected systems, with a particular focus on leveraging artificial intelligence and related technologies to advance health and human flourishing.